Detail
Article
Online article
FT
Medvik - BMC
  • Something wrong with this record ?

Pharmacological stimulation of Wnt/beta-catenin signaling pathway attenuates the course of thioacetamide-induced acute liver failure

E. Koblihová, I. Mrázová, Z. Vaňourková, H. Maxová, S. Kikerlová, Z. Husková, M. Ryska, J. Froněk, Z. Vernerová

. 2020 ; 69 (1) : 113-126. [pub] 20191219

Language English Country Czech Republic

Document type Journal Article

Persistent link   https://www.medvik.cz/link/bmc20017811

Acute liver failure (ALF) is known for extremely high mortality rate, the result of widespread damage of hepatocytes. Orthotopic liver transplantation is the only effective therapy but its application is limited by the scarcity of donor organs. Given the importance in the liver biology of Wnt/beta-catenin signaling pathway, we hypothesized that its stimulation could enhance hepatocyte regeneration and attenuate the course of thioacetamide (TAA)-induced ALF in Lewis rats. Chronic treatment with Wnt agonist was started either immediately after hepatotoxic insult ("early treatment") or when signs of ALF had developed ("late treatment"). Only 23 % of untreated Lewis rats survived till the end of experiment. They showed marked increases in plasma alanine aminotransferase (ALT) activity and bilirubin and ammonia (NH3) levels; plasma albumin decreased significantly. "Early" and "late" Wnt agonist treatment raised the final survival rate to 69 % and 63 %, respectively, and normalized ALT, NH3, bilirubin and albumin levels. In conclusion, the results show that treatment with Wnt agonist attenuates the course of TAA-induced ALF in Lewis rats, both with treatment initiated immediately after hepatotoxic insult and in the phase when ALF has already developed. Thus, the pharmacological stimulation of Wnt/beta-catenin signaling pathway can present a new approach to ALF treatment.

References provided by Crossref.org

Bibliography, etc.

Literatura

000      
00000naa a2200000 a 4500
001      
bmc20017811
003      
CZ-PrNML
005      
20210214102048.0
007      
ta
008      
201110s2020 xr ad f 000 0|eng||
009      
AR
024    7_
$a 10.33549/physiolres.934071 $2 doi
035    __
$a (PubMed)31852203
040    __
$a ABA008 $b cze $d ABA008 $e AACR2
041    0_
$a eng
044    __
$a xr
100    1_
$a Koblihová, Eva $7 xx0191639 $u Department of Surgery, Second Faculty of Medicine, Charles University and Central Military Hospital, Prague, Czech Republic
245    10
$a Pharmacological stimulation of Wnt/beta-catenin signaling pathway attenuates the course of thioacetamide-induced acute liver failure / $c E. Koblihová, I. Mrázová, Z. Vaňourková, H. Maxová, S. Kikerlová, Z. Husková, M. Ryska, J. Froněk, Z. Vernerová
504    __
$a Literatura
520    9_
$a Acute liver failure (ALF) is known for extremely high mortality rate, the result of widespread damage of hepatocytes. Orthotopic liver transplantation is the only effective therapy but its application is limited by the scarcity of donor organs. Given the importance in the liver biology of Wnt/beta-catenin signaling pathway, we hypothesized that its stimulation could enhance hepatocyte regeneration and attenuate the course of thioacetamide (TAA)-induced ALF in Lewis rats. Chronic treatment with Wnt agonist was started either immediately after hepatotoxic insult ("early treatment") or when signs of ALF had developed ("late treatment"). Only 23 % of untreated Lewis rats survived till the end of experiment. They showed marked increases in plasma alanine aminotransferase (ALT) activity and bilirubin and ammonia (NH3) levels; plasma albumin decreased significantly. "Early" and "late" Wnt agonist treatment raised the final survival rate to 69 % and 63 %, respectively, and normalized ALT, NH3, bilirubin and albumin levels. In conclusion, the results show that treatment with Wnt agonist attenuates the course of TAA-induced ALF in Lewis rats, both with treatment initiated immediately after hepatotoxic insult and in the phase when ALF has already developed. Thus, the pharmacological stimulation of Wnt/beta-catenin signaling pathway can present a new approach to ALF treatment.
650    _2
$a zvířata $7 D000818
650    _2
$a preklinické hodnocení léčiv $7 D004353
650    _2
$a játra $x účinky léků $x metabolismus $7 D008099
650    _2
$a akutní selhání jater $x chemicky indukované $x farmakoterapie $x metabolismus $7 D017114
650    _2
$a mužské pohlaví $7 D008297
650    _2
$a potkani inbrední LEW $7 D011917
650    _2
$a thioacetamid $7 D013853
650    _2
$a proteiny Wnt $x agonisté $7 D051153
650    _2
$a signální dráha Wnt $x účinky léků $7 D060449
650    _2
$a beta-katenin $x metabolismus $7 D051176
655    _2
$a časopisecké články $7 D016428
700    1_
$a Mrázová, Iveta $7 xx0227642 $u Center for Experimental Medicine, Institute for Clinical and Experimental Medicine, Prague, Czech Republic; Department of Pathophysiology, Second Faculty of Medicine, Charles University, Prague, Czech Republic
700    1_
$a Vaňourková, Zdeňka, $d 1973- $7 xx0074217 $u Center for Experimental Medicine, Institute for Clinical and Experimental Medicine, Prague, Czech Republic
700    1_
$a Maxová, Hana, $d 1968- $7 xx0037102 $u Department of Pathophysiology, Second Faculty of Medicine, Charles University, Prague, Czech Republic
700    1_
$a Kikerlová, Soňa, $d 1978- $7 xx0256886 $u Center for Experimental Medicine, Institute for Clinical and Experimental Medicine, Prague, Czech Republic
700    1_
$a Husková, Zuzana, $d 1978- $7 xx0074206 $u Center for Experimental Medicine, Institute for Clinical and Experimental Medicine, Prague, Czech Republic
700    1_
$a Ryska, Miroslav, $d 1953- $7 skuk0004934 $u Department of Surgery, Second Faculty of Medicine, Charles University and Central Military Hospital, Prague, Czech Republic
700    1_
$a Froněk, Jiří, $d 1970- $7 xx0061406 $u Department of Transplantation Surgery, Institute for Clinical and Experimental Medicine, Prague, Czech Republic
700    1_
$a Vernerová, Zdenka, $d 1960-2020 $7 jo2002104672 $u Center for Experimental Medicine, Institute for Clinical and Experimental Medicine, Prague, Czech Republic; Department of Pathology, Third Faculty of Medicine, Charles University, Prague, Czech Republic
773    0_
$w MED00003824 $t Physiological research $x 1802-9973 $g Roč. 69, č. 1 (2020), s. 113-126
856    41
$u https://pubmed.ncbi.nlm.nih.gov/31852203 $y Pubmed
910    __
$a ABA008 $b A 4120 $c 266 $y p $z 0
990    __
$a 20201110 $b ABA008
991    __
$a 20210214102005 $b ABA008
999    __
$a ok $b bmc $g 1619111 $s 1108003
BAS    __
$a 3
BAS    __
$a PreBMC
BMC    __
$a 2020 $b 69 $c 1 $d 113-126 $e 20191219 $i 1802-9973 $m Physiological research $n Physiol. Res. (Print) $x MED00003824
LZP    __
$b NLK118 $a Pubmed-20201110

Find record

Citation metrics

Archiving options